Updated Jul 16, 2026
Dunsire Deborah has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Deborah Dunsire is an experienced executive in the pharmaceutical industry, currently serving as a director at McKesson Corporation. She has held various leadership roles in healthcare and has a strong background in pharmaceutical operations and strategy.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 7.8K | $0.00 |
Deborah Dunsire is an experienced executive in the pharmaceutical industry, currently serving as a director at McKesson Corporation. She has held various leadership roles in healthcare and has a strong background in pharmaceutical operations and strategy.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dunsire Deborah profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.